- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Register
- Human nationally authorised products
- Ergot derivatives - (dihydroergotoxine) - Art.31 (
Pharmaceuticals - Community Register
List of nationally authorised medicinal products for human use
Ergot derivatives - (dihydroergotoxine) - Art.31 (amend or suspend) (re-examination has been asked)
| Product name: | Ergot derivatives - (dihydroergotoxine) - Art.31 (amend or suspend) (re-examination has been asked) |
| Also marketed in the EU under the name(s): | CAPERGYL, Dihydroergotoxinum Filofarm, Hydergin, HYDERGINA, Hydergine, Ibexone, Redergin, SECATOXIN FORTE, STOFILAN |
| Active substance: | dihydroergotoxine |
| Indication: | Not available |
| Marketing Authorisation Holder: | Not applicable |
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 20/12/2013 | Referral | EMEA/H/A-31/1325 | (2013)9747 of 18/12/2013 |
CONTACT
EU links
Directorate General Health & Consumers